Summary:
- The article critically examines the medicalization of "Low T" (hypogonadism) and the aggressive marketing of testosterone replacement therapy (TRT).
- It emphasizes the importance of distinguishing between normal age-related hormonal fluctuations and clinically significant endocrine disorders.
- It warns against the risks of "lifestyle" testosterone supplementation, highlighting the lack of long-term safety data and the potential for adverse cardiovascular and physiological side effects.